{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:07:09Z","timestamp":1781608029093,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Nehemia Rubin Excellence in Biomedical Research, TELEM Program, Sheba Medical Center, Tel Hashomer, Israel"},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1845\/16"],"award-info":[{"award-number":["1845\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1845\/16"],"award-info":[{"award-number":["1845\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1845\/16"],"award-info":[{"award-number":["1845\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Currently there are no reliable biomarkers for early detection of Alzheimer's disease (AD) at the preclinical stage. This study assessed the pupil light reflex (PLR) for focal red and blue light\u00a0stimuli in central and peripheral retina in 125 cognitively normal middle age subjects (45\u201371\u00a0years old) at high risk for AD due to a family history of the disease (FH+), and 61 age-similar subjects with no family history of AD (FH\u2212) using Chromatic Pupilloperimetry coupled with Machine Learning (ML). All subjects had normal ophthalmic assessment, and normal retinal and optic nerve thickness by optical coherence tomography. No significant differences were observed between groups in cognitive function and volumetric brain MRI. Chromatic pupilloperimetry-based ML models were highly discriminative in differentiating subjects with and without AD family history, using transient PLR for focal red (primarily cone-mediated), and dim blue (primarily rod-mediated) light stimuli. Features associated with transient pupil response latency (PRL) achieved Area Under the Curve Receiver Operating Characteristic (AUC-ROC)\u00a0of 0.90\u2009\u00b1\u20090.051 (left-eye) and 0.87\u2009\u00b1\u20090.048 (right-eye). Parameters associated with the contraction arm of the rod and cone-mediated PLR were more discriminative compared to parameters associated with the relaxation arm and melanopsin-mediated PLR. Significantly shorter PRL for dim blue light was measured in the FH+ group in two test targets in the temporal visual field in right eye that had highest relative weight in the ML algorithm (mean\u2009\u00b1\u2009standard error, SE 0.449\u00a0s\u2009\u00b1\u20090.007\u00a0s vs. 0.478\u00a0s\u2009\u00b1\u20090.010\u00a0s, p\u2009=\u20090.038). Taken together our study suggests that subtle focal changes in pupil contraction latency may be detected in subjects at high risk to develop AD, decades before the onset of AD clinical symptoms. The dendrites of melanopsin containing retinal ganglion cells may be affected very early at the preclinical stages of AD.<\/jats:p>","DOI":"10.1038\/s41598-022-13999-0","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T09:08:56Z","timestamp":1655284136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Machine learning for comprehensive prediction of high risk for Alzheimer\u2019s disease based on chromatic pupilloperimetry"],"prefix":"10.1038","volume":"12","author":[{"given":"Yael","family":"Lustig-Barzelay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Sharvit-Ginon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mrejen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shada","family":"Dallasheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Livny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Schnaider Beeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramit","family":"Ravona-Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-1779","authenticated-orcid":false,"given":"Ygal","family":"Rotenstreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"13999_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","volume":"9","author":"A Wimo","year":"2013","unstructured":"Wimo, A. et al. The worldwide economic impact of dementia 2010. Alzheimers Dement. 9, 1-11.e3 (2013).","journal-title":"Alzheimers Dement."},{"key":"13999_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn, B., Stein, P. & Cavazzoni, P. Approval of aducanumab for Alzheimer disease-the FDA\u2019s perspective. JAMA Intern. Med. 181, 1276\u20131278 (2021).","journal-title":"JAMA Intern. Med."},{"key":"13999_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2174\/1567205013666160930112125","volume":"14","author":"D Hsu","year":"2017","unstructured":"Hsu, D. & Marshall, G. A. Primary and secondary prevention trials in Alzheimer disease: Looking back, moving forward. Curr. Alzheimer Res. 14, 426\u2013440 (2017).","journal-title":"Curr. Alzheimer Res."},{"key":"13999_CR4","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/01.wnl.0000295996.54210.69","volume":"69","author":"JL Cummings","year":"2007","unstructured":"Cummings, J. L., Doody, R. & Clark, C. Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69, 1622\u20131634 (2007).","journal-title":"Neurology"},{"issue":"Suppl 2","key":"13999_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/ije\/20.Supplement_2.S13","volume":"20","author":"CM van Duijn","year":"1991","unstructured":"van Duijn, C. M. et al. Familial aggregation of Alzheimer\u2019s disease and related disorders: A collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20(Suppl 2), S13-20 (1991).","journal-title":"Int. J. Epidemiol."},{"key":"13999_CR6","first-page":"948","volume":"60","author":"H Payami","year":"1997","unstructured":"Payami, H. et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): Effects of family history and apolipoprotein E genotype. Am. J. Hum. Genet. 60, 948\u2013956 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"13999_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jama.287.3.329","volume":"287","author":"RC Green","year":"2002","unstructured":"Green, R. C. et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 287, 329\u2013336 (2002).","journal-title":"JAMA"},{"key":"13999_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.maturitas.2009.12.014","volume":"65","author":"BB Bendlin","year":"2010","unstructured":"Bendlin, B. B. et al. Midlife predictors of Alzheimer\u2019s disease. Maturitas 65, 131\u2013137 (2010).","journal-title":"Maturitas"},{"key":"13999_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.b.32399","volume":"171B","author":"D Scarabino","year":"2016","unstructured":"Scarabino, D., Gambina, G., Broggio, E., Pelliccia, F. & Corbo, R. M. Influence of family history of dementia in the development and progression of late-onset Alzheimer\u2019s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 171B, 250\u2013256 (2016).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"13999_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","volume":"4","author":"PJ Snyder","year":"2016","unstructured":"Snyder, P. J. et al. Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease. Alzheimers Dement. (Amst.) 4, 169\u2013178 (2016).","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"13999_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/aos.14121","volume":"97","author":"JA van de Kreeke","year":"2019","unstructured":"van de Kreeke, J. A. et al. Retinal layer thickness in preclinical Alzheimer\u2019s disease. Acta Ophthalmol. 97, 798\u2013804 (2019).","journal-title":"Acta Ophthalmol."},{"key":"13999_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber, J. et al. Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: What we know, what we don\u2019t, and how to move forward. Alzheimers Dement. 16, 229\u2013243 (2020).","journal-title":"Alzheimers Dement."},{"key":"13999_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia, C. et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann. Neurol. 79, 90\u2013109 (2016).","journal-title":"Ann. Neurol."},{"key":"13999_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/diagnostics8010019","volume":"8","author":"CA Hall","year":"2018","unstructured":"Hall, C. A. & Chilcott, R. P. Eyeing up the future of the pupillary light reflex in neurodiagnostics. Diagnostics (Basel) 8, 19 (2018).","journal-title":"Diagnostics (Basel)"},{"key":"13999_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fneur.2019.00360","volume":"10","author":"PS Chougule","year":"2019","unstructured":"Chougule, P. S., Najjar, R. P., Finkelstein, M. T., Kandiah, N. & Milea, D. Light-induced pupillary responses in Alzheimer\u2019s disease. Front. Neurol. 10, 360 (2019).","journal-title":"Front. Neurol."},{"key":"13999_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/jnnp.62.6.665","volume":"62","author":"R Prettyman","year":"1997","unstructured":"Prettyman, R., Bitsios, P. & Szabadi, E. Altered pupillary size and darkness and light reflexes in Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatr. 62, 665\u2013668 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"13999_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/15672050113106660163","volume":"10","author":"S Frost","year":"2013","unstructured":"Frost, S. et al. Pupil response biomarkers for early detection and monitoring of Alzheimer\u2019s disease. Curr. Alzheimer Res. 10, 931\u2013939 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"13999_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1212\/WNL.50.3.642","volume":"50","author":"E Ferrario","year":"1998","unstructured":"Ferrario, E. et al. Is videopupillography useful in the diagnosis of Alzheimer\u2019s disease?. Neurology 50, 642\u2013644 (1998).","journal-title":"Neurology"},{"key":"13999_CR19","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3233\/JAD-140969","volume":"42","author":"DM Bittner","year":"2014","unstructured":"Bittner, D. M., Wieseler, I., Wilhelm, H., Riepe, M. W. & M\u00fcller, N. G. Repetitive pupil light reflex: Potential marker in Alzheimer\u2019s disease?. J. Alzheimers Dis. 42, 1469\u20131477 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"13999_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0167-8760(02)00122-8","volume":"47","author":"E Granholm","year":"2003","unstructured":"Granholm, E. et al. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer\u2019s and Parkinson\u2019s disease. Int. J. Psychophysiol. 47, 95\u2013115 (2003).","journal-title":"Int. J. Psychophysiol."},{"key":"13999_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF03324716","volume":"19","author":"DF Fotiou","year":"2007","unstructured":"Fotiou, D. F. et al. Pupil reaction to light in Alzheimer\u2019s disease: Evaluation of pupil size changes and mobility. Aging Clin. Exp. Res. 19, 364\u2013371 (2007).","journal-title":"Aging Clin. Exp. Res."},{"key":"13999_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijpsycho.2009.01.011","volume":"73","author":"DF Fotiou","year":"2009","unstructured":"Fotiou, D. F. et al. Cholinergic deficiency in Alzheimer\u2019s and Parkinson\u2019s disease: Evaluation with pupillometry. Int. J. Psychophysiol. 73, 143\u2013149 (2009).","journal-title":"Int. J. Psychophysiol."},{"key":"13999_CR23","doi-asserted-by":"crossref","first-page":"7935406","DOI":"10.1155\/2017\/7935406","volume":"2017","author":"S Frost","year":"2017","unstructured":"Frost, S. et al. Evaluation of cholinergic deficiency in preclinical Alzheimer\u2019s disease using pupillometry. J. Ophthalmol. 2017, 7935406 (2017).","journal-title":"J. Ophthalmol."},{"key":"13999_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0167-8760(00)00099-4","volume":"37","author":"F Fotiou","year":"2000","unstructured":"Fotiou, F., Fountoulakis, K. N., Tsolaki, M., Goulas, A. & Palikaras, A. Changes in pupil reaction to light in Alzheimer\u2019s disease patients: A preliminary report. Int. J. Psychophysiol. 37, 111\u2013120 (2000).","journal-title":"Int. J. Psychophysiol."},{"key":"13999_CR25","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/15672050113109990154","volume":"10","author":"SM Frost","year":"2013","unstructured":"Frost, S. M. et al. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Curr. Alzheimer Res. 10, 790\u2013796 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"13999_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40520-015-0321-8","volume":"27","author":"D Fotiou","year":"2015","unstructured":"Fotiou, D., Kaltsatou, A., Tsiptsios, D. & Nakou, M. Evaluation of the cholinergic hypothesis in Alzheimer\u2019s disease with neuropsychological methods. Aging Clin. Exp. Res. 27, 727\u2013733 (2015).","journal-title":"Aging Clin. Exp. Res."},{"key":"13999_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/bjophthalmol-2018-312425","volume":"103","author":"GP Van Stavern","year":"2019","unstructured":"Van Stavern, G. P., Bei, L., Shui, Y.-B., Huecker, J. & Gordon, M. Pupillary light reaction in preclinical Alzheimer\u2019s disease subjects compared with normal ageing controls. Br. J. Ophthalmol. 103, 971\u2013975 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"13999_CR28","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ophtha.2009.02.007","volume":"116","author":"R Kardon","year":"2009","unstructured":"Kardon, R. et al. Chromatic pupil responses: Preferential activation of the melanopsin-mediated versus outer photoreceptor-mediated pupil light reflex. Ophthalmology 116, 1564\u20131573 (2009).","journal-title":"Ophthalmology"},{"key":"13999_CR29","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1167\/iovs.11-7586","volume":"52","author":"JC Park","year":"2011","unstructured":"Park, J. C. et al. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Investig. Ophthalmol. Vis. Sci. 52, 6624\u20136635 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"13999_CR30","doi-asserted-by":"publisher","first-page":"14242","DOI":"10.1523\/JNEUROSCI.1321-12.2012","volume":"32","author":"JJ Gooley","year":"2012","unstructured":"Gooley, J. J. et al. Melanopsin and rod-cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans. J. Neurosci. 32, 14242\u201314253 (2012).","journal-title":"J. Neurosci."},{"key":"13999_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fneur.2019.00076","volume":"10","author":"AV Rukmini","year":"2019","unstructured":"Rukmini, A. V., Milea, D. & Gooley, J. J. Chromatic pupillometry methods for assessing photoreceptor health in retinal and optic nerve diseases. Front. Neurol. 10, 76 (2019).","journal-title":"Front. Neurol."},{"key":"13999_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/15.3.13","volume":"15","author":"JC Park","year":"2015","unstructured":"Park, J. C. & McAnany, J. J. Effect of stimulus size and luminance on the rod-, cone-, and melanopsin-mediated pupillary light reflex. J. Vis. 15, 13 (2015).","journal-title":"J. Vis."},{"key":"13999_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226197","volume":"14","author":"AJ Oh","year":"2019","unstructured":"Oh, A. J. et al. Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep\u2013wake activity in pre-symptomatic Alzheimer\u2019s disease. PLoS\u00a0One 14, e0226197 (2019).","journal-title":"PLoS\u00a0One"},{"key":"13999_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fnins.2020.00780","volume":"14","author":"M Romagnoli","year":"2020","unstructured":"Romagnoli, M. et al. Chromatic pupillometry findings in Alzheimer\u2019s disease. Front. Neurosci. 14, 780 (2020).","journal-title":"Front. Neurosci."},{"key":"13999_CR35","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1167\/iovs.18-23767","volume":"59","author":"S Haj Yahia","year":"2018","unstructured":"Haj Yahia, S. et al. Effect of stimulus intensity and visual field location on rod- and cone-mediated pupil response to focal light stimuli. Investig. Ophthalmol. Vis. Sci. 59, 6027\u20136035 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"13999_CR36","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.ophtha.2016.05.038","volume":"123","author":"R Chibel","year":"2016","unstructured":"Chibel, R. et al. Chromatic multifocal pupillometer for objective perimetry and diagnosis of patients with retinitis pigmentosa. Ophthalmology 123, 1898\u20131911 (2016).","journal-title":"Ophthalmology"},{"key":"13999_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/OPTH.S191486","volume":"13","author":"D Ben Ner","year":"2019","unstructured":"Ben Ner, D. et al. Chromatic pupilloperimetry for objective diagnosis of Best vitelliform macular dystrophy. Clin. Ophthalmol. 13, 465\u2013475 (2019).","journal-title":"Clin. Ophthalmol."},{"key":"13999_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.9.8.10","volume":"9","author":"I Sher","year":"2020","unstructured":"Sher, I. et al. Chromatic pupilloperimetry measures correlate with visual acuity and visual field defects in retinitis pigmentosa patients. Transl. Vis. Sci. Technol. 9, 10 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"13999_CR39","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1167\/iovs.12-11127","volume":"54","author":"A Skaat","year":"2013","unstructured":"Skaat, A. et al. Pupillometer-based objective chromatic perimetry in normal eyes and patients with retinal photoreceptor dystrophies. Investig. Ophthalmol. Vis. Sci. 54, 2761\u20132770 (2013).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"13999_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus, R. T., Dean, R. L., Beer, B. & Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408\u2013414 (1982).","journal-title":"Science"},{"key":"13999_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbr.2009.12.047","volume":"221","author":"AHEA Van Beek","year":"2011","unstructured":"Van Beek, A. H. E. A. & Claassen, J. A. H. R. The cerebrovascular role of the cholinergic neural system in Alzheimer\u2019s disease. Behav. Brain Res. 221, 537\u2013542 (2011).","journal-title":"Behav. Brain Res."},{"key":"13999_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira, T. H., Guimaraes, I. M., Silva, F. R. & Ribeiro, F. M. Alzheimer\u2019s disease: Targeting the cholinergic system. Curr. Neuropharmacol. 14, 101\u2013115 (2016).","journal-title":"Curr. Neuropharmacol."},{"key":"13999_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s004010051031","volume":"97","author":"LF Scinto","year":"1999","unstructured":"Scinto, L. F. et al. Focal pathology in the Edinger\u2013Westphal nucleus explains pupillary hypersensitivity in Alzheimer\u2019s disease. Acta Neuropathol. 97, 557\u2013564 (1999).","journal-title":"Acta Neuropathol."},{"key":"13999_CR44","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0197-4580(01)00235-4","volume":"22","author":"LF Scinto","year":"2001","unstructured":"Scinto, L. F. et al. Selective cell loss in Edinger\u2013Westphal in asymptomatic elders and Alzheimer\u2019s patients. Neurobiol. Aging 22, 729\u2013736 (2001).","journal-title":"Neurobiol. Aging"},{"key":"13999_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0006-8993(78)90533-4","volume":"159","author":"H Hultborn","year":"1978","unstructured":"Hultborn, H., Mori, K. & Tsukahara, N. The neuronal pathway subserving the pupillary light reflex. Brain Res. 159, 255\u2013267 (1978).","journal-title":"Brain Res."},{"key":"13999_CR46","first-page":"473","volume":"13","author":"A Tales","year":"2001","unstructured":"Tales, A. et al. The pupillary light reflex in aging and Alzheimer\u2019s disease. Aging (Milano) 13, 473\u2013478 (2001).","journal-title":"Aging (Milano)"},{"key":"13999_CR47","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/s41598-021-84318-2","volume":"11","author":"JJ McAnany","year":"2021","unstructured":"McAnany, J. J. et al. Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer\u2019s disease. Sci. Rep. 11, 4824 (2021).","journal-title":"Sci. Rep."},{"key":"13999_CR48","doi-asserted-by":"publisher","first-page":"24317","DOI":"10.1073\/pnas.1912959116","volume":"116","author":"KV Do","year":"2019","unstructured":"Do, K. V. et al. Elovanoids counteract oligomeric \u03b2-amyloid-induced gene expression and protect photoreceptors. Proc. Natl. Acad. Sci. U. S. A. 116, 24317\u201324325 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"13999_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103327","volume":"24","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Gao, F., Ma, Y., Xue, T. & Shen, Y. Identification of early-onset photoreceptor degeneration in transgenic mouse models of Alzheimer\u2019s disease. iScience 24, 103327 (2021).","journal-title":"iScience"},{"key":"13999_CR50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nature03387","volume":"433","author":"DM Dacey","year":"2005","unstructured":"Dacey, D. M. et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 433, 749\u2013754 (2005).","journal-title":"Nature"},{"key":"13999_CR51","doi-asserted-by":"publisher","unstructured":"Hosmer, D. W., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression. (Wiley, 2013). https:\/\/doi.org\/10.1002\/9781118548387.","DOI":"10.1002\/9781118548387"},{"key":"13999_CR52","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.neurobiolaging.2013.01.006","volume":"34","author":"PA Williams","year":"2013","unstructured":"Williams, P. A. et al. Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer\u2019s disease. Neurobiol. Aging 34, 1799\u20131806 (2013).","journal-title":"Neurobiol. Aging"},{"key":"13999_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan, R. J. et al. Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 216 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"13999_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-200623","volume":"78","author":"R Ravona-Springer","year":"2020","unstructured":"Ravona-Springer, R. et al. The Israel registry for Alzheimer\u2019s prevention (IRAP) study: Design and baseline characteristics. J. Alzheimers Dis. 78, 777\u2013788 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"13999_CR55","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archneur.55.3.360","volume":"55","author":"RJ Ellis","year":"1998","unstructured":"Ellis, R. J. et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch. Neurol. 55, 360\u2013365 (1998).","journal-title":"Arch. Neurol."},{"key":"13999_CR56","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/nimg.2000.0582","volume":"11","author":"J Ashburner","year":"2000","unstructured":"Ashburner, J. & Friston, K. J. Voxel-based morphometry\u2014The methods. Neuroimage 11, 805\u2013821 (2000).","journal-title":"Neuroimage"},{"key":"13999_CR57","unstructured":"Gaser, C. & Dahnke, R. CAT-A Computational Anatomy Toolbox for the Analysis of Structural MRI Data. (2016)."},{"key":"13999_CR58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/01688638608401314","volume":"8","author":"GJ Chelune","year":"1986","unstructured":"Chelune, G. J. & Baer, R. A. Developmental norms for the Wisconsin Card Sorting test. J. Clin. Exp. Neuropsychol. 8, 219\u2013228 (1986).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"13999_CR59","unstructured":"Wechsler, D. Wechsler Adult Intelligence Scale-Revised. 1\u2013156 (Psychological Corporation, 1981)."},{"key":"13999_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF01109053","volume":"2","author":"RW Elwood","year":"1991","unstructured":"Elwood, R. W. The Wechsler Memory Scale-Revised: Psychometric characteristics and clinical application. Neuropsychol. Rev. 2, 179\u2013201 (1991).","journal-title":"Neuropsychol. Rev."},{"key":"13999_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/325439a0","volume":"325","author":"JL Schnapf","year":"1987","unstructured":"Schnapf, J. L., Kraft, T. W. & Baylor, D. A. Spectral sensitivity of human cone photoreceptors. Nature 325, 439\u2013441 (1987).","journal-title":"Nature"},{"key":"13999_CR62","first-page":"20122987","volume":"280","author":"HJ Bailes","year":"2013","unstructured":"Bailes, H. J. & Lucas, R. J. Human melanopsin forms a pigment maximally sensitive to blue light (\u03bbmax \u2248 479 nm) supporting activation of G(q\/11) and G(i\/o) signalling cascades. Proc. Biol. Sci. 280, 20122987 (2013).","journal-title":"Proc. Biol. Sci."},{"key":"13999_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cobeha.2019.06.004","volume":"30","author":"M Spitschan","year":"2019","unstructured":"Spitschan, M. Melanopsin contributions to non-visual and visual function. Curr. Opin. Behav. Sci. 30, 67\u201372 (2019).","journal-title":"Curr. Opin. Behav. Sci."},{"key":"13999_CR64","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.visres.2007.12.016","volume":"48","author":"RSL Young","year":"2008","unstructured":"Young, R. S. L. & Kimura, E. Pupillary correlates of light-evoked melanopsin activity in humans. Vis. Res. 48, 862\u2013871 (2008).","journal-title":"Vis. Res."},{"key":"13999_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/jcss.1997.1504","volume":"55","author":"Y Freund","year":"1997","unstructured":"Freund, Y. & Schapire, R. E. A decision-theoretic generalization of on-line learning and an application to boosting. J. Comput. Syst. Sci. 55, 119\u2013139 (1997).","journal-title":"J. Comput. Syst. Sci."},{"key":"13999_CR66","first-page":"1","volume":"12","author":"G Kalton","year":"1986","unstructured":"Kalton, G. & Kasprzyk, D. The treatment of missing survey data. Surv. Methodol. 12, 1\u201316 (1986).","journal-title":"Surv. Methodol."},{"key":"13999_CR67","first-page":"31","volume":"22","author":"G Kalton","year":"1982","unstructured":"Kalton, G. & Kasprzyk, D. Imputing for missing survey responses. Am. Stat. Assoc. 22, 31 (1982).","journal-title":"Am. Stat. Assoc."},{"key":"13999_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1214\/ss\/1032280214","volume":"11","author":"TJ DiCiccio","year":"1996","unstructured":"DiCiccio, T. J. et al. Bootstrap confidence intervals. Stat. Sci. 11, 189\u2013228 (1996).","journal-title":"Stat. Sci."},{"key":"13999_CR69","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","volume":"19","author":"J Carpenter","year":"2000","unstructured":"Carpenter, J. & Bithell, J. Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians. Stat. Med. 19, 1141\u20131164 (2000).","journal-title":"Stat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13999-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:23:45Z","timestamp":1669353825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13999-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13999"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13999-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IS and YR have patents and patent application regarding chromatic pupilloperimetry methods and device, handled by the Sheba Medical Center. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9945"}}